Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Uveal Melanoma 1Recurrence 1Neoplasm, Residual 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Peripheral Blood Stem Cell Transplantation 3fludarabine phosphate 2treosulfan 1Whole-Body Irradiation 1Tacrolimus 1Polymerase Chain Reaction 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Immunoenzyme Techniques 1Filgrastim 1Decitabine 1Cytarabine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bronchoscopy 1Bronchoalveolar Lavage 1Biopsy 1Azacitidine 1Antilymphocyte Serum 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myelodysplastic-Myeloproliferative Diseases × treosulfan × Clear all
NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡